Grady T A, Pigott T A, L'Heureux F, Hill J L, Bernstein S E, Murphy D L
Department of Psychiatry, Duke University Medical Center, Durham, NC 27710.
Am J Psychiatry. 1993 May;150(5):819-21. doi: 10.1176/ajp.150.5.819.
In a double-blind, crossover study, 13 fluoxetine-treated patients with obsessive-compulsive disorder were given adjuvant buspirone and placebo for 4 weeks each. There were no significant differences between buspirone and placebo in obsessive-compulsive, depressive, or anxiety symptoms.
在一项双盲交叉研究中,13名接受氟西汀治疗的强迫症患者分别接受了为期4周的辅助性丁螺环酮和安慰剂治疗。丁螺环酮和安慰剂在强迫症、抑郁或焦虑症状方面没有显著差异。